R eactive Oxygen Species (ROS) have been shown to modulate vascular signaling in endothelium, smooth muscle, and adventitia, regulate vascular hypertrophy, inflammation, remodeling, intracellular calcium, and disturb nitric oxide bioactivity. 1, 2 Since Griendling et al discovered the activation of NAD(P)H oxidase by angiotensin II (Ang II), 3 researches have focused on the regulation of this enzyme in Ang II signaling/Ang II-induced hypertension both in vitro and in vivo. Vascular NAD(P)H oxidase consists of multiple subunits including p22 phox , p40 phox , p47 phox , p67 phox , Rac1, and unique catalytic subunits, Nox isoforms (gp91 phox homologue). 4 The signaling mechanisms for the rapid activation of NAD(P)H oxidase by Ang II have been identified using cultured aortic vascular smooth muscle cells (VSMCs). Ang II rapidly activates PLC to increase intracellular calcium and diacylglycerol levels, which causes the activation of protein kinase C (PKC). PKC phosphorylates p47 phox and releases ROS from Nox subunits. Subsequently, ROS activates cSrc, EGF-receptor, PI3-kinase, and Rac1, leading to the secondary activation of NAD(P)H oxidase to augment the intracellular ROS levels. 4 These events occur within 30 minutes in cultured VSMCs. Considering the ROS generation associated with hypertension in vivo, the latter transcriptional upregulation of NAD(P)H oxidase subunits by Ang II might be more important. Ang II upregulates the expressions of NAD(P)H oxidase subunits after more than 4 hours including p22 phox , Nox2 (gp91 phox ), p47 phox , and p67 phox , 5 however the mechanisms of transcriptional regulations for NAD(P)H oxidase subunits have not fully been elucidated yet.
In this issue of Circulation Research, Ni and colleagues identified that Ets-1 was a critical transcriptional regulator of p47 phox induced by Ang II in vitro and in vivo. 6 Ets-1 has been known as a proto-oncogene transcription factor to induce matrix-degradation proteins such as collagenase, plasminogen activation inhibitor-1(PAI-1), and matrixmetalloproteinases. Ets-1 can be induced by TNF-␣, endothelin-1, prostanoid(s), and platelet-derived growth factor, [7] [8] suggesting an implication in vascular inflammation. Indeed, this group previously reported that Ets-1 was a critical factor needed to induce cyclin-dependent kinase, PAI-I, vascular cells adhesion molecule-1, and monocyte chemoattractant protein-1 in response to Ang II. In Ets-1 Ϫ/Ϫ mice, the vascular inflammation by Ang II infusion, which was represented by the recruitment of T cell and macrophage to vessel wall, was blunted, although hypertensive response was preserved. 9 In this article, the authors carefully seek the molecular mechanisms to regulate the expression of NAD(P)H oxidase subunits by Ets-1. The augmentation of superoxide and hydrogen peroxide (H 2 O 2 ) generations by Ang II were markedly attenuated in aorta from Ets-1 Ϫ/Ϫ mice or VSMCs with siRNA for Ets-1. siRNA for Ets-1 also blunted the upregulation of p47 phox without affecting the expression of Nox1, Nox4, Rac1, p22 phox , and p67 phox by Ang II. They used gel-shift assay, luciferase reporter assay, and chromatin immunoprecipitation assay with deletion mutant of p47 phox promoter, and identified the Ϫ45 Ets-1-binding promoter region as essential for the induction of p47 phox . They developed peptides to inhibit ETS-1 bindings (DN-Ets-1 peptides) and delivered them to the Ang II-infused mice in vivo. DN-Ets-1 peptides attenuated medial hypertrophy and aortic ROS generation without affecting hypertensive response to Ang II.
This article impacts the field of hypertension research in 3 major ways. First, the authors demonstrate the importance of p47 phox induction for aortic ROS generation in Ang II-induced hypertension. p47 phox is phosphorylated at S359/S370/S379 by PKC, which causes association with p22 phox . S303/S304 of p47 phox were also phosphorylated to augment the catalytic activity of NAD(P)H oxidase. 4 We expressed S303A/S304A mutant p47 phox in VSMCs to suppress the redox-sensitive signal by Ang II. 10 The posttranslational modifications of p47 phox by Ang II are critical for the rapid activation of NAD(P)H oxidase.
The importance of p47 phox expression in Ang II-induced hypertension was also shown by Landmesser and colleagues. 11 An increase in superoxide generation of aorta by Ang II was blunted in p47 phoxϪ/Ϫ mice but rose 3-fold in control. Hypertensive response to Ang II was modestly decreased in p47 phoxϪ/Ϫ mice. Consistent with these observations and the results by Ni and colleagues, 6 p47 phox induction is essential for aortic ROS generation and vascular inflammation in Ang II-infusion, whereas it is not required for the hypertensive response. Because Ets-1 is a critical transcriptional regulator for p47 phox , it is a potential therapeutic target for vascular inflammation.
Second, this study showed the importance of transcriptional regulation of the NAD(P)H oxidase. The authors clearly show the specific induction of p47 phox by Ets-1 without affecting the expressions of other subunits by Ang II. AP-1 was shown to regulate the expression of p67 phox in The opinions expressed in this editorial are not necessarily those of the editors or of the American Heart Association. monoytes, 12 however, vascular NAD(P)H oxidase may contain an alternative to p67 phox subunit, NoxA1, 4 and the transcriptional regulation of vascular NAD(P)H oxidases are largely unknown. Stimulation of VSMCs with Ang II activates many of early genes, including AP-1 (c-fos, c-jun), NF-␤(p50, p65), ATF/CREB, hypoxia-inducible factor-1 (HIF-1), Egr-1, STAT1, and Nrf-2. 1, 13 Wilson et al 14 showed that H 2 O 2 upregulated translations of Ets-1, which were mediated by the activation of Nrf-2/ARE (antioxidant response element). It is possible that the rapid activation of NADPH oxidase causes the expression of Ets-1 by redoxsensitive mechanism, which in turn induces p47 phox for the booster effects of ROS generation by Ang II.
Redox-Sensitive Thiols Can Be Critical Targets for NAD(P)H Oxidase
Although the molecular mechanisms for the redox-sensitive signaling are not fully known, growing evidence indicates the importance of thiols modification by ROS. 15 ROS can modify the redox-sensitive thiols to sulfenylation (RSOH), sulfinylation (RSO 2 H), and S-glutathiolation (RSSG). We previously found that Ang II increased ROS generation from NAD(P)H oxidase, which caused the activation of Ras via S-glutathiolation at Cys118 in VSMCs. Because many of the oncogene/transcription factors can be upregulated by the activation of Ras, the mechanism may be implicated in the ROS-mediated transcriptional regulations. 1, 10 There are several other candidates for thiol-containing proteins targeted by ROS. Phosphatases have critical redox-sensitive thiols in the center of catalytic sites and the oxidation of them by ROS decreases their activity. 16 Rac1 contains a redox-sensitive thiol to modulate its function. 17 Caspase can be inhibited by S-glutathiolation, 18 and Thioredoxin (Trx) and glutaredoxin (Grx) can reverse thiol-modifications of Ras, phosphatases, and caspases. 10, 15, 18 Interestingly, another Trx superfamily, protein disulfide isomerase, is associated with NAD(P)H oxidase and supports ROS generation. 19 Transcriptional factors can be also regulated by ROS via redox-sensitive thiols. Cys179 on IKK␤ is S-glutathiolated by ROS from Nox1, which causes NF-␤ activation. 20 ROS oxidizes the reactive thiol on Keap1 to dissociate Nrf-2, leading to the Nrf-2transcription. In contrast, many transcription factors such as AP-1 and NF-␤ have redox-sensitive thiols in the DNAbinding sites and their modifications disturb DNA binding. The effects of ROS on transcription may differ according to the localization of ROS. 13
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Third, the authors used unique peptides to block Ets-1 transcription for in vivo models. DN-Ets-1 peptides contained HIV-TAT protein membrane-transduction domains to promote intracellular delivery, especially to the nucleus. In the past, Pagano and colleagues generated gp91-ds-tat peptides, which inhibited the interaction between Nox2 and p47 phox and efficiently decreased vascular ROS from NAD(P)H oxidase. 21 Similar peptide drugs may be useful for targeting proteins related with NAD(P)H oxidase. With recent advances for understanding the regulation of NAD(P)H oxidase, we can create multiple strategies to modulate NAD(P)H oxidase activity (Figure) . The AT1 receptor blocker attenuates Ang II signaling. Statin, a HMG-CoA reductase inhibitor, decreases farnysyl/geranylgeranyl pyrophosphate, leading to the suppression of Ras/Rac1. 22 Inhibition of glucose 6-phosphate dehydrogenase decreases intracellular NADPH and ROS from NAD(P)H oxidase, 23 although it may weaken the antioxidant defenses. Many of the redox-sensitive thiols and thiol-reducing enzymes (Trx/Grx/PDI) can be the downstream targets. 15 Moreover, redox-sensitive transcriptional factors can be new targets for the suppression of NAD(P)H oxidase. Targeting NAD(P)H oxidase. The mechanism to regulate NAD(P)H oxidase by Ang II is shown. PKC and c-Src activates NAD(P)H oxidase with the phosphorylation of p47 phox . Ets-1 upregulates p47 phox expression. ROS from NADPH oxidase can modify thiols on the multiple target proteins and Trx/Grx reverses them. There are various strategies for targeting NAD(P)H oxidase in the system, including unique subunits, kinases/phosphatases, small GTPases, thiol-mediated regulations, and transcription factors.
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